A reappraisal of the mucoactive activity and clinical efficacy of bromhexine
A Zanasi, M Mazzolini, A Kantar - Multidisciplinary respiratory medicine, 2017 - Springer
Since its introduction to the market in 1963, bromhexine, an over-the-counter drug, has been
investigated for its activity in animal models and in humans with diverse respiratory …
investigated for its activity in animal models and in humans with diverse respiratory …
A between-patient, double-blind comparison of S-carboxymethylcysteine and bromhexine in chronic obstructive bronchitis
M Aylward - Current Medical Research and Opinion, 1973 - Taylor & Francis
S-carboxymethylcysteine was compared with bromhexine in a double-blind between-patient
clinical trial in bronchiticpatients with mucoid sputum. Oral S-carboxymethylcysteine …
clinical trial in bronchiticpatients with mucoid sputum. Oral S-carboxymethylcysteine …
Beyond the lungs: exploring diverse applications of bromhexine and ambroxol
The respiratory tract is commonly affected in multisystem disorders. Although many drugs
have been developed to target various components of these diseases, there is still a need …
have been developed to target various components of these diseases, there is still a need …
Effects of baicalin and wogonin on mucin release from cultured airway epithelial cells
HJ Heo, HJ Lee, YS Kim, SS Kang… - … Journal Devoted to …, 2007 - Wiley Online Library
Scutellaria baicalensis Georgi has been used for the treatment of diverse chronic
inflammatory diseases including respiratory disease in oriental medicine and its major …
inflammatory diseases including respiratory disease in oriental medicine and its major …
Mucoactive agents in the therapy of upper respiratory airways infections: fair to describe them just as mucoactive?
F Scaglione, O Petrini - Clinical Medicine Insights: Ear, Nose …, 2019 - journals.sagepub.com
Background: Upper and lower respiratory tract infections are common conditions for which
medical advice is sought, and their management relies on the use of prescription and over …
medical advice is sought, and their management relies on the use of prescription and over …
Role of bromhexine in exacerbations of bronchiectasis: double-blind randomized multicenter study versus placebo
D Olivieri, A Ciaccia, E Marangio, S Marsico, T Todisco… - Respiration, 1991 - karger.com
The effectiveness of bromhexine in the treatment of patients with bronchiectasis, in a stage
of clinical exacerbation, was assessed in a double-blind, placebo-controlled trial involving …
of clinical exacerbation, was assessed in a double-blind, placebo-controlled trial involving …
Clinical effectiveness of a combination of bromhexine and amoxicillin in lower respiratory tract infection. A randomized controlled trial.
A multicenter double-blind randomized trial was performed in 22 teaching hospitals to
compare the clinical effectiveness of the combination of amoxicillin (CAS 26787-78-0) plus …
compare the clinical effectiveness of the combination of amoxicillin (CAS 26787-78-0) plus …
Clinical results in the treatment of chronic obstructive bronchitis with ambroxol in comparison with bromhexine (author's transl)
KJ Wiessmann, K Niemeyer - Arzneimittel-forschung, 1978 - europepmc.org
Preclinical studies of trans-4-[(2-amino-3, 5-dibromobenzyl)-amino]-cyclohexanol
hydrochloride (ambroxol, NA 872), the metabolite VIII of bromhexine, show that it is superior …
hydrochloride (ambroxol, NA 872), the metabolite VIII of bromhexine, show that it is superior …
Enhancement of lung levels of antibiotics by ambroxol and bromhexine
V Deretic, GS Timmins - Expert opinion on drug metabolism & …, 2019 - Taylor & Francis
Introduction: Major unmet needs remain for improved antibiotic treatment in lung infections.
While development of new antibiotics is needed to overcome resistance, other approaches …
While development of new antibiotics is needed to overcome resistance, other approaches …
Ambroxol: a multifaceted molecule with additional therapeutic potentials in respiratory disorders of childhood
D Paleari, GA Rossi, G Nicolini… - Expert opinion on drug …, 2011 - Taylor & Francis
Introduction: Mucoactive drugs are currently used to cleanse the respiratory tract following
disturbance of the normal mucociliary clearance due to mucous hyperproduction and/or …
disturbance of the normal mucociliary clearance due to mucous hyperproduction and/or …